Literature DB >> 16307550

The genetics of staphylococcal biofilm formation--will a greater understanding of pathogenesis lead to better management of device-related infection?

F Fitzpatrick1, H Humphreys, J P O'Gara.   

Abstract

Staphylococcus epidermidis and Staphylococcus aureus are common causes of biofilm-mediated prosthetic device-related infection. The polysaccharide adhesion mechanism encoded by the ica operon is currently the best understood mediator of biofilm development, and represents an important virulence determinant. More recently, the contributions of other virulence regulators, including the global regulators agr, sarA and sigmaB, to the biofilm phenotype have also been investigated. Nevertheless, little has changed at the bedside; the clinical and laboratory diagnosis of device-related infection can be difficult, and biofilm resistance frequently results in failure of therapy. This review assesses the way in which advances in the understanding of biofilm genetics may impact on the clinical management of device-related infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16307550     DOI: 10.1111/j.1469-0691.2005.01274.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  46 in total

1.  Antimicrobial Activity of Bacillus subtilis KATMIRA1933 and Bacillus amyloliquefaciens B-1895 Against Staphylococcus aureus Biofilms Isolated from Wound Infection.

Authors:  Ammar Algburi; Halah M Al-Hasani; Thurya K Ismael; Alyaa Abdelhameed; Richard Weeks; Aleksey M Ermakov; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2021-02       Impact factor: 4.609

2.  The yjeQ gene is required for virulence of Staphylococcus aureus.

Authors:  Tracey L Campbell; James Henderson; David E Heinrichs; Eric D Brown
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

3.  SarZ promotes the expression of virulence factors and represses biofilm formation by modulating SarA and agr in Staphylococcus aureus.

Authors:  Sandeep Tamber; Ambrose L Cheung
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

4.  Depression of biofilm formation and antibiotic resistance by sarA disruption in Staphylococcus epidermidis.

Authors:  Ju-Hong Tao; Chang-Sheng Fan; Shan-E Gao; Hai-Jiao Wang; Guo-Xin Liang; Qing Zhang
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

Review 5.  Staphylococcus aureus biofilms: properties, regulation, and roles in human disease.

Authors:  Nathan K Archer; Mark J Mazaitis; J William Costerton; Jeff G Leid; Mary Elizabeth Powers; Mark E Shirtliff
Journal:  Virulence       Date:  2011-09-01       Impact factor: 5.882

6.  IL-12 promotes myeloid-derived suppressor cell recruitment and bacterial persistence during Staphylococcus aureus orthopedic implant infection.

Authors:  Cortney E Heim; Debbie Vidlak; Tyler D Scherr; Curtis W Hartman; Kevin L Garvin; Tammy Kielian
Journal:  J Immunol       Date:  2015-03-11       Impact factor: 5.422

Review 7.  From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis.

Authors:  Kristi L Frank; José Luis Del Pozo; Robin Patel
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

8.  Impact of food-related environmental factors on the adherence and biofilm formation of natural Staphylococcus aureus isolates.

Authors:  Daniel Vázquez-Sánchez; Olivier Habimana; Askild Holck
Journal:  Curr Microbiol       Date:  2012-10-14       Impact factor: 2.188

9.  Impact of sarA on antibiotic susceptibility of Staphylococcus aureus in a catheter-associated in vitro model of biofilm formation.

Authors:  Elizabeth C Weiss; Horace J Spencer; Sonja J Daily; Brian D Weiss; Mark S Smeltzer
Journal:  Antimicrob Agents Chemother       Date:  2009-03-16       Impact factor: 5.191

10.  Investigation of biofilm formation in clinical isolates of Staphylococcus aureus.

Authors:  James E Cassat; Chia Y Lee; Mark S Smeltzer
Journal:  Methods Mol Biol       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.